Ward MA, Fang G, Richards KL, Walko CM, Earnshaw SR, Happe LE, Blalock S. Treatment interruption and regimen change in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia. JHEOR. 2015 Apr;2(2):181-91.
Davis KL, Gutierrez B, Zyczynski T, Kaye JA. Real-world treatment patterns in men with castration-resistant prostate cancer receiving docetaxel. JHEOR. 2015 Jan 6;2(2):119-30. doi: 10.36469/9894
Freund DA, Hurley RE, Adamache KW, Mauskopf J. The performance of urban and public hospitals and NHCs (neighborhood health centers) under Medicaid capitation programs. Hosp Health Serv Adm. 1990 Jan 1;35(4):525-46.